Despite screenings which are finding more tumors, men with prostate cancer aren't living longer. That's what Marshfield Clinic researchers found during a long-running study on the issue. Marshfield Clinic's Dr. Doug Reding says the results show better prostate cancer screenings don't translate into a longer life for patients.
The study began in 1992 to determine whether certain screening methods were effective in reducing deaths, not only from prostate cancer, but lung, colorectal and ovarian cancers as well. Reding says they were not. Of the more than 154,000 participants,76,000 thousand were men. Marshfield Clinic enrolled 17,000 patients ages 55-to-74. The results were released in Wednesday's on-line version of the New England Journal of Medicine .